Telemedicine to benefit the most from remote patient monitoring tools: Poll
The COVID-19 pandemic has led to a surge in the use of remote patient monitoring (RPM) tools to monitor patients…
Latest Digital Disruption
-
1 month
-
1 month
-
1 month
-
8 months
-
1 month
-
1 month
-
1 month
-
8 months
Companies seek to improve operational efficiency with digital transformation: Survey
The COVID-19 pandemic triggered unexpected challenges in the business environment prompting pharmaceutical companies to accelerate the adoption of digital transformation…
ZyVersa engages PPD for FSGS study, on crossover fundraising roadshow
ZyVersa Therapeutics has enlisted the CRO PPD to manage its upcoming Phase IIa focal segmental glomerulosclerosis (FSGS) study, said CEO Stephen Glover. The company is initiating a roadshow…
Overview of infectious disease clinical trials in China
The coronavirus outbreak, though the majority of cases have been in China, has affected many aspects of global life, especially businesses and travel. The virus…
vTv Therapeutics joins the oral drug market for type one diabetics
Earlier this month, vTv Therapeutics announced positive phase two results for its oral antidiabetic drug, TTP-399, when used as an…
AI healthcare firm Viz.ai to expand clinical trial platform Viz RECRUIT
Applied artificial intelligence (AI) healthcare company Viz.ai has announced new algorithms and expanded features for its clinical trial platform, Viz…
OncoSec purchases Phesi ClinSite licence for immune-oncology trials
OncoSec Medical has secured a multi-year ClinSite licence from clinical development analytics products and services provider Phesi. ClinSite is a…
June’s top news stories
AstraZeneca reports positive results from CASPIAN trial of Imfinzi AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
May’s top news stories
Novartis reports positive results from Phase III trial in asthma Novartis reported that the first clinical trial in its Phase…
April’s top news stories
I-Mab and MorphoSys begin Phase III study of blood cancer drug Chinese clinical-stage biopharmaceutical company I-Mab Biopharma and German biotech…
UKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The Complete Guide to Freelancers in MedTech
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…